Leerink and Piper Sandler acted as joint book running managers for the offering.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNYA:
- FDA Lifts Hold on Tenaya’s MyPEAK-1 Trial
- Tenaya Therapeutics files to sell common stock, no amount given
- Tenaya Therapeutics announces interim data from cohort one of RIDGE-1 trial
- Tenaya Therapeutics announces clinical hold on MyPEAK-1 trial lifted by FDA
- Tenaya Therapeutics Reports Improved Financials Amid Strategic Focus